retatrutide nejm 2023 obesity trial ly3437943 just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Retatrutide Research Guide: What the
Description
Its unclear if or when this program will return as a standalone offering
Moreover, offering oral GLP1 options allows primary care providers to meet patient preferences without compromising efficacy
Approximately 24 weeks following the standard titration schedule, assuming the medication is well-tolerated at each step
[DOI] [PMC free article] [PubMed] [Google Scholar] 86.Fala L
Safe & Effective: Made with natural ingredients and a science-backed formula, our nasal ring is FDA- and GMP-certified for quality and safety
